Table 3.

Change in medication adherence blood pressure and hemoglobin A1c between baseline and 3 months by study group.

Outcome	Control participants (n=21)			Intervention participants (n=21)			F testa (df)		P value
	Baseline	3 months	Baseline		3 months
Medication adherence, mean (SD); range: 0-8b,c	4.0 (1.3)	5.5 (2.1)	4.4 (1.3)		5.6 (2.0)	0.5 (1, 4)		.50
Change	N/Ad	1.5	N/A		1.2	N/A		N/A
Systolic BPe, mean (SD) mm Hg	137.4 (17.8)	135.1 (19.5)	139.9 (18.3)		130.9 (17.4)	3.1 (1, 26)		.10
Change	N/A	−2.3	N/A		−9.0	N/A		N/A
Diastolic BP, mean (SD) mm Hg	88.5 (10.9)	87.4 (10.3)	84.1 (14.1)		80.2 (16.0)	2.9 (1, 27)		.10
Change	−1.1	N/A	−3.8		N/A	N/A		N/A
Hemoglobin A1c, n (%)	7.3 (2.8)	7.8 (2.5)	8.5 (3.0)		8.2 (2.7)	1.1 (1, 30)		.30
Change	N/A	+0.5	N/A		−0.3	N/A		N/A

^aF statistic results of the analysis of covariance.

^bHigher scores indicate better adherence.

^cThe eight-item Morisky Medication Adherence Scale (MMAS-8) scoring and coding presented in the study was done using the electronic Morisky Widget MMAS-8 software. The use of the Morisky Widget MMAS-8 software, copyright registration number TX 8-816-517, is protected by US copyright laws. Permission for use of the Morisky Widget MMAS-8 software is required and was obtained for this research. A license agreement is available from MMAS Research LLC 14725 NE 20th St Bellevue, WA 98007, United States; strubow@morisky.org.

^dN/A: not applicable.

^eBP: blood pressure.